Legend Biotech Corporation (LEGN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 4.01B |
| Enterprise Value | 3.52B |
| P/E Ratio | -21.57 |
| PEG Ratio | 0.5 |
| Price/Sales Ratio | 4.76 |
| Price/Book Ratio | 5.6 |
| Enterprise/Revenue | 4.54 |
| Enterprise/EBITDA | -28.55 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.22 |
| Operating Margin | -0.12 |
| Return On Assets | -0.16 |
| Return On Equity | -0.25 |
| Revenue | 1.03B |
| Revenue/Share | 6.16 |
| Gross Profit | 620.8M |
| EBITDA | -232.3M |
| Net Income | -296.8M |
| Diluted EPS | -1.6 |
| Total Cash | 834.63M |
| Total Cash/Share | 4.52 |
| Total Debt | 389.31M |
| Total Debt/Equity | 0.4 |
| Current Ratio | 2.13 |
| Book Value Per Share | 5.24 |
| 52-Week Change | -13.32 |
| 52-Week High | 45.3 |
| 52-Week Low | 16.24 |
| Moving Average 50 Days | 27.74 |
| Moving Average 200 Days | 25.69 |
| Average Volume | 2.67M |
| Shares Outstanding | 184.94M |
| % Held by Institutions | 51.66 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |